NCT01858688View on ClinicalTrials.gov

A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2018

Study Completion Date

April 30, 2023

Conditions
Prostate Cancer
Interventions
DEVICE

Multiparametric MRI

an MRI of the prostate will be performed

PROCEDURE

Prostate biopsy

a biopsy of the prostate will be performed according to standard procedures for men on active surveillance

Trial Locations (2)

02215

Brigham and Women's Hospital, Boston

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT01858688 - A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer | Biotech Hunter | Biotech Hunter